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Background: Although screening, brief intervention, and referral to treatment (SBIRT) is an evidence-based
technique that, in some health-care settings, has been shown to cost-effectively reduce alcohol and drug use,
research on the efficacy of SBIRT among criminal offender populations is limited. Such populations have a high
prevalence of drug and alcohol use but limited access to intervention, and many are at risk for post-release relapse
and recidivism. Thus, there exists a need for treatment options for drug-involved offenders of varying risk levels to
reduce risky behaviors or enter treatment.
Methods/design: This protocol describes an assessment of SBIRT feasibility and effectiveness in a criminal justice
environment. Eight-hundred persons will be recruited from a large metropolitan jail, with the experimental group
receiving an intervention depending on risk level and the control group receiving minimal intervention. The
intervention will assess the risk level for drug and alcohol misuse by inmates, providing those at low or medium
risk a brief intervention in the jail and referring those at high risk to community treatment following release. In
addition, a brief treatment (eight-session) option will be available. Using data from a 12-month follow-up interview,
the primary study outcomes are a reduction in drug and alcohol use, while secondary outcomes include
participation in treatment, rearrest, quality of life, reduction in HIV risk behaviors, and costs of SBIRT.
Expected value: Individual reductions in alcohol and drug use can have significant effects on public health and
safety when observed over a large population at risk for substance-use problems. With wider dissemination
statewide or nationwide, a relatively low-cost intervention such as SBIRT could offer demonstrated benefits in this
population.
Trial registration: Clinical Trials Government Identifier, NCT01683643.
Keywords: Screening, brief intervention, and referral to treatment (SBIRT), Offenders, Jail, Protocol, Pragmatic
randomized trialIntroduction
Nearly all people with a history of drug use enter the crim-
inal justice system at some time in their drug use career,
frequently on a recurring basis. Drug use is closely associ-
ated with crime, and its prevalence among offenders is
high [1-3]. Drug use, particularly when involving injection,
also contributes to increased risk of HIV transmission [4].
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distribution, and reproduction in any mediummonths of release from incarceration [5,6], highlighting
the importance of providing intervention options at the
pre-release or reentry phase of the offender’s incarceration.
While many offenders use drugs at levels that do not
necessarily require treatment, they are still at risk of pro-
gressing to abuse or dependence or of engaging in un-
healthy behavior. Interventions for offenders at low or
moderate risk are largely lacking within the criminal justice
system. One strategy to address this would be to provide
early intervention to offenders using approaches that are
appropriate to level of risk. Such an intervention would
provide appropriate care earlier than would otherwise beed Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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reducing risky behaviors. Offenders who are serving a jail
sentence, particularly on drug charges, are at a “teachable
moment” in which they may be amenable to an interven-
tion designed to reduce their risk of relapse and re-arrest
and improve other behaviors.
Screening, brief intervention, and referral to treatment
(SBIRT) provides universal low-cost screening to a target
population using brief, valid, and reliable screening instru-
ments. Based on results from the screening, counselors,
health educators, or other staff can identify people at dif-
ferent risk levels and provide types and intensities of inter-
vention in accordance with the level of risk, ranging from
information or brief intervention for low-risk users to re-
ferral to formal treatment for high-risk users [7]. Through
a combination of prevention/early intervention and formal
treatment, SBIRT is a public health approach intended to
have a positive impact on the drug- and alcohol-related
behavior of a broad user population, rather than on the
much smaller population of those diagnosed with abuse
or dependence. Studies in health-care settings have re-
ported that the costs of SBIRT are relatively low, and that
the benefit-cost ratio is favorable ($3-$4 for every dollar
spent) [8].
Less research has been conducted on brief interven-
tions or SBIRT for drugs than for alcohol. But many ran-
domized studies of brief intervention for drug use have
found statistically significant effects for at least one of
the primary outcomes [9-15] an exception is [16]. Also,
published articles on SBIRT projects for drug use funded
by the US Substance Abuse and Mental Health Services
Administration (SAMHSA) have reported significant re-
ductions in drug use and other problems from baseline
to follow-up [17-20], although use of a single-group de-
sign in these projects precludes strong conclusions about
the causal effect of SBIRT on drug use. Also, limited re-
search bearing on the use of brief intervention or SBIRT
with offenders is available. Three randomized studies sug-
gest that brief intervention can result in positive behav-
ioral change among offenders [12,21,22].
In summary, although SBIRT has been found to be ef-
fective in some populations in health-care and other set-
tings, it remains an empirical question whether SBIRT is a
feasible intervention for offenders and whether it encour-
ages treatment participation, reduces substance use, and
results in other longer term benefits. Given the large pro-
portion of offenders who use drugs and alcohol and who
experience problems associated with such use, a relatively
low-cost intervention such as SBIRT could have significant
public health and public safety implications.
Study aims
The aims of the SBIRT for Offenders study are to a) as-
sess the effectiveness of SBIRT with jail inmates in termsof participation in a graduated series of interventions
(brief intervention, brief treatment, and referral to longer
term treatment), depending on risk level; b) determine
the effectiveness of SBIRT with jail inmates on public
health and public safety outcomes at 12 months following
study admission, namely, drug use, alcohol use, criminal
activity, arrest, reincarceration, HIV risk behaviors, and
quality of life; and c) determine the cost of providing an
SBIRT intervention to jail inmates. To accomplish these
aims, we will recruit jail inmates who are completing their
sentence in a large Los Angeles County jail. The study will
be a collaboration between the University of California at
Los Angeles (UCLA) Integrated Substance Abuse Pro-
grams (ISAP), the Los Angeles County Sheriff ’s Depart-
ment, Homeless Health Care Los Angeles (HHC-LA), and
the Substance Abuse Prevention and Control Division of
the Los Angeles County Department of Public Health.
Methods/design
Setting and participants
Screening and brief intervention will occur in two jails
in Los Angeles County. Men’s Central Jail houses ap-
proximately 5000 male inmates from throughout Los
Angeles County. The Twin Towers Detention Facility
houses about 400 female inmates from throughout the
county. The majority of inmates at both facilities have
been sentenced on misdemeanor charges. As noted above,
brief treatment will be conducted by trained counselors
from HHC-LA, either in person at the HHC-LA treat-
ment program or by telephone. Participants needing lon-
ger term treatment will be referred to one of the county’s
Community Assessment Services Centers.
Since SBIRT is intended to be a universal intervention
within a target setting, all adult (18+) male and female
inmates who are within two weeks of scheduled release
and who are available during the times that recruitment
is conducted will be eligible to participate, with the fol-
lowing exceptions: those who 1) lack fluency in English
or Spanish, 2) are unwilling to provide locator informa-
tion for follow-up, 3) plan to leave the Los Angeles area
within 12 months, 4) already have a referral to treatment
following release from jail, or 5) are unable to provide
informed consent owing to cognitive impairment.
SBIRT for Offenders intervention
The conceptual framework of SBIRT is informed by empir-
ical and theoretical considerations. There is a continuum of
substance use problems and awareness of those problems
among users. Screening, brief intervention, and referral to
treatment systematically identifies, through screening, an
individual’s level of risk and provides (or at least offers) an
intervention that is appropriate to the assessed level of risk.
The type and intensity of the intervention depend on the
level of risk and the degree to which the individual is ready
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(Pre-Contemplation, Contemplation, Preparation, Action,
and Maintenance [23]). Most participants in the study will
be in the Pre-Contemplation or Contemplation stage and,
in any case, are not likely to be actively seeking treatment.
For the brief intervention component of SBIRT, the thera-
peutic technique to help clients move to the Preparation or
the Action stage is typically motivational interviewing,
using the FRAMES model (Feedback, Responsibility, Ad-
vice to change, Menu of options, Empathy, and Self-efficacy
[24]). The SBIRT model used in the study will include the
components typical of SBIRT models generally: 1) screen-
ing to identify level of risk and, depending on the level of
risk, 2) information, 3) brief intervention, and 4) referral to
treatment.
Screening and risk-level interventions
Screening is intended to identify individuals at varying
levels of risk associated with the use of alcohol and/or
drugs. It is not intended to provide a formal diagnosis
(which is the function of clinical assessment), but rather
to provide guidance for deciding which level of interven-
tion may be needed to address the identified level of risk.
As explained below, all participants in the study will
complete the Alcohol, Smoking, and Substance Involve-
ment Screening Test (ASSIST) [25] for screening. The
ASSIST is an eight-item instrument developed by the
World Health Organization (WHO) to screen for haz-
ardous, harmful, and dependent use of alcohol, tobacco,
and drugs. The ASSIST typically takes about 5-10 mi-
nutes to administer, although it can take longer depend-
ing on the number of drugs used over the lifetime. For
each drug endorsed, questions are asked about fre-
quency of use in the three months prior to the current
incarceration, problems related to use, dependence indica-
tors, and injection drug use. Following ASSIST administra-
tion, separate risk scores are calculated, with scores falling
within a low-, moderate-, or high-risk range. Table 1 shows
the risk-level scores for alcohol and drugs and the indicated
intervention for each risk level, as specified in the WHO
brief intervention manual [26]. We will use a computer-
based version of the ASSIST to make the screening faster






Low risk 0-10 0-3 Feedback on ASSIST score,
literature
Moderate risk 11-26 4-26 Feedback on ASSIST score,
literature, brief intervention
High risk 27+ 27+ Feedback on ASSIST score,
literature, brief intervention,
referral to treatmentLow risk for drug and/or alcohol use
Study participants in the SBIRT group who score at low
risk on the ASSIST for drug or alcohol use are notified
by the health educator of their screening score and its
meaning and are given literature on drug and alcohol
use, HIV risk behaviors, and HIV testing. The health
educator provides clients with a list of treatment re-
sources should their behavior change in the future or to
share with affected family or friends.
Moderate risk for drug and/or alcohol use
For users of drugs and alcohol who score at moderate
risk on the ASSIST, the health educator provides feed-
back on the screening score and provides a brief inter-
vention to encourage cessation of use, a description of
brief treatment and its benefits, and a referral to brief or
other treatment if the client requests it. The health edu-
cator also provides participants at this risk level with lit-
erature on the effects of drug and alcohol use and on
HIV risk behaviors and HIV testing. (Although the AS-
SIST assesses tobacco risk, because of time constraints
the intervention will not address tobacco use; however,
the literature provided will include advice on smoking
cessation).
The brief intervention takes about 15-20 minutes and
uses a motivational interviewing approach. The health
educator reviews the screening score and its meaning,
assesses readiness to change, establishes goals with the
client, and reviews strategies for change. One of the strat-
egies is the opportunity to participate in a brief treatment
intervention upon release from jail. If requested by the cli-
ent, the health educator provides a referral to more inten-
sive treatment.
Brief treatment (BT) is an individual-based interven-
tion that is intended for clients who score at moderate
risk. It is designed mainly to help clients who have few
complicating problems to learn and develop skills to
change their behavior. It is also appropriate for those
who score at high risk but who are unwilling to commit
to longer term treatment or for those who are on a wait-
ing list for longer term treatment. It is offered at no cost
to participants assigned to the SBIRT condition. The study
will use a BT model developed for a SAMHSA-funded
SBIRT program in San Diego, which was also used in a pre-
vious Los Angeles SBIRT project; it has been modified as
needed for use in the study. This manualized treatment uti-
lizes elements of two evidence-based practices: motivational
interviewing and cognitive behavioral therapy [24,27,28]
and consists of eight highly structured sessions delivered
in person or by telephone. The initial session consists of
orientation to BT and a needs assessment using the Addic-
tion Severity Index-Lite (ASI-Lite) [29]. In Sessions 2-7, the
counselor builds on the findings of the initial assessment
by monitoring the client’s progress toward meeting self-
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vention, HIV risk behaviors, and other identified psy-
chosocial needs. In Session 8, the counselor reviews with
the client his or her progress toward meeting self-defined
goals, provides positive verbal reinforcement, and discusses
future steps towards goals. If the client requests more in-
tensive treatment, the counselor provides a referral as de-
scribed below.
High risk for drug and/or alcohol use
For clients who score at high risk, the health educator
gives feedback on the screening score and conducts a
brief intervention to encourage the client to accept and
follow through on a referral to a specialty treatment pro-
gram. Information on HIV risk behaviors and testing is
also provided. The health educator refers clients to one
of 19 Community Assessment Services Center (CASC)
offices located throughout Los Angeles County; the CASCs
conduct assessments for substance use disorders and other
problems and then refer clients to appropriate treatment
programs, most of which offer comprehensive services, in-
cluding HIV/AIDS education and HIV testing and counsel-
ing. The health educator provides the client with the name,
telephone number, and address of the CASC located near
where he or she lives or works. The county Department of
Public Health has multiple sources of funding for persons
who wish to receive treatment but do not have health insur-
ance. Should the client prefer BT, the health educator sends
the person’s contact information to the counselor, who will
arrange for an in-person or telephone appointment.
Selection and training of SBIRT health educators
and counselors
Homeless Health Care-Los Angeles (HHC-LA) will pro-
vide SBIRT to jail inmates assigned to the intervention
group. The HHC-LA health educators (who provide
screening and brief intervention) and counselors (who
provide BT) will be individuals who have experience
working with offenders with substance use problems.
They will need to receive clearance to work in the jails.
They will participate in a week-long training in study de-
sign, administration, and scoring of the ASSIST, brief
intervention, BT, and procedures for referral to treat-
ment. Training will be provided by the principal investi-
gator (study purpose and design), the project director
(ASSIST, brief intervention, referral), and a consultant
on BT. Training in the components of the intervention
will be conducted in a small-group format with use of
presentations, demonstrations, role-playing, and video-
taping of practice sessions to ensure that the health edu-
cators and counselors are familiar with the material,
have mastered the techniques, and have received appro-
priate feedback. The BT consultant will provide refresher
training every six months. In addition, a clinical supervisorat HHC-LA will hold weekly meetings with health educa-
tors and counselors. Staff will be bilingual in English and
Spanish, and literature will be available in English and
Spanish.
Human subjects approval
The study procedures and the informed consent form
have been approved by the UCLA General Campus In-
stitutional Review Board.
Power analysis for sample size
Average effect sizes from meta-analyses of brief inter-
ventions for alcohol problems [30-32] range from a stan-
dardized mean difference of 0.18 to 0.43. Although no
meta-analyses have been conducted on brief interven-
tions for drug problems, effect sizes from primary stud-
ies involving illicit drugs [9-11,14,33] range from 0.13 to
0.84. Most of these studies focus on clients in primary
care or other health-care settings. No experimental stud-
ies have reported outcomes for SBIRT (as opposed to
brief intervention) with offenders. Since previous research
provides limited guidance for estimating the expected ef-
fect sizes for the primary outcomes of the study, it seems
reasonable to assume a small effect size; that is, a standard-
ized mean difference of about 0.20 for a reduction in alco-
hol and drug use from baseline to 12-month follow-up.
The power analysis (using the RMASS2 program; [34]) as-
sumes alpha = 0.05 (two-sided), power = 0.80, an attrition
rate of 15%, and an autoregressive variance-covariance
structure, with a moderate correlation of 0.50 between
levels of use at baseline and follow-up. With an expected
effect size of 0.20 for the primary outcomes, the sample
size is 778, equally divided between the two study groups.
This estimate is similar for different variance-covariance
structures, including a random-effects structure. We set
the total sample at 800. To assess possible treatment by
gender interactions, the sample recruited will include
25% women.
Recruitment, randomization, and baseline interviews
We expect to recruit approximately 33 participants per
month, although recruitment over the first three or four
months may be somewhat lower given the time that it
will take to establish a smooth and efficient process for
recruitment and intervention within the jails. Recruit-
ment should take about 24 months. Based on previous
studies of brief intervention or SBIRT that reported refusal
rates, we estimate that about 25% of inmates approached
will refuse to participate.
Each week, Los Angeles County Sheriff ’s Department
staff will provide ISAP research staff with a list of names,
identification numbers, and scheduled release dates for
inmates who are eligible for study participation for that
week. On designated recruitment days, research staff will
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tody staff will call up inmates and escort them to the re-
cruitment location within the jail.
The interviewer will explain the nature of the study and
review the informed consent form with the potential par-
ticipants. If the person agrees to participate, the researcher
will obtain the required signatures on the consent form
and provide a copy to the participant. Using a set of ran-
domly ordered opaque envelopes prepared by ISAP’s Data
Management Center, the interviewer will randomly assign
the participant to the SBIRT group or the comparison
group and will inform him or her of the assignment. For
inmates who refuse to participate in the study, the inter-
viewer will record the reason(s) provided, if any, and basic
gender, age, and race/ethnicity based on visual cues.
If the participant is randomized to the SBIRT group, the
interviewer will administer the baseline interview, obtain
locator information for the follow-up interview, and then
direct the person to the health educator, who will adminis-
ter the ASSIST; the participant will then receive the ap-
propriate intervention based on ASSIST score.
If the participant is randomized to the control group,
the interviewer will administer the baseline interview and
locator form and then administer the ASSIST. Having the
interviewer administer the ASSIST to the control partici-
pants accomplishes two purposes: first, it ensures that we
have comparable data on risk levels for participants in
both study groups, and second, it ensures that the control
participants receive the ASSIST in a research context ra-
ther than in a clinical context, thus strengthening the clin-
ical contrast between the two groups. (As discussed later,
there may still be a research effect on outcomes; however,
this is unavoidable if we wish to collect self-report baseline
data that cannot be obtained from records.) Following the
interview, the interviewer will inform control participants
of their risk level based on the ASSIST and will provide
them with literature on reducing drug and alcohol use
and HIV risk behaviors and a list of treatment programs
in Los Angeles County. Control participants will not re-
ceive a brief intervention or a referral to treatment, but
they may, of course, decide to enroll in treatment or seek
other help on their own, which will be determined in the
follow-up interview or through records.
Data sources
Research staff will be bilingual in English and Spanish,
and consent forms, instruments, and other materials will
be available in English and Spanish.
Baseline interview
Given the setting, the nature of the intervention, and the
need to encourage participation, the baseline interview
will be kept as brief as possible (about 30 minutes, rather
than the hour or more that baseline interviews usuallytake). The domains covered will include demographics,
drug and alcohol use, treatment history, stage of change
and readiness for treatment, HIV risk behaviors, and
crime and criminal justice history. Drug and alcohol his-
tory will be available from the ASSIST and other stand-
ard drug-use assessments. Other items will be drawn
from the Intake Instrument of the Criminal Justice Drug
Abuse Treatment Studies Cooperative (funded by the
National Institute on Drug Abuse [NIDA]); the Univer-
sity of Rhode Island Change Assessment Scale (URICA
[35]); and the HIV risk-behavior questions used in the
NIDA Clinical Trials Network.
Follow-up interview
The 12-month follow-up interview will last about one hour
and will include questions and scales that measure out-
comes, namely, drug and alcohol use (using the ASSIST),
participation in treatment, quality of life, HIV risk behav-
iors, crimes committed, and criminal justice contacts.
Quality of life will be measured with the WHO Quality of
Life–Bref Survey [36]. All participants (SBIRT and control)
who report having received treatment since baseline will
also be asked about their satisfaction with the treatment
they received (Client Satisfaction Questionnaire-8 [37]).
Biological measures for drug and alcohol use
At the follow-up interview, participants will be requested
to provide two oral fluids samples, one of which will be
analyzed for drugs, the other for alcohol, both using
onsite test kits [38,39]. Compared with urine testing,
oral fluid testing is less intrusive, is more convenient, is
more easily observed, makes adulteration more difficult,
and provides results that have sufficient sensitivity and
specificity for research purposes. The drug test will provide
results for opiates, cocaine, methamphetamine, amphet-
amine, marijuana, and phencyclidine—the drugs most com-
monly used in southern California. At the direction of our
Institutional Review Board, we will not collect oral fluids at
follow-up interviews conducted with incarcerated subjects.
In addition, oral fluids samples will not be collected from
participants who are interviewed by telephone.
Administrative records
We will obtain records-based data on arrests and incar-
ceration over the follow-up period from the Los Angeles
Sheriff ’s Department and the California Department of
Justice and on participation in publicly funded treatment
from the Substance Abuse Prevention and Control office
of the Los Angeles County Department of Public Health.
Cost data
Data on the costs of the SBIRT intervention will be col-
lected using the Brief Drug Abuse Treatment Cost Analysis
Program (www.datcap.com [40]), which has been used to
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programs, including brief intervention [41]. Costs will be
collected in Year 3 and will include staff training and mon-
itoring; staff time for screening, brief intervention, and BT;
time spent by sheriff ’s department employees; equipment
and supplies; and other costs associated with the inter-
vention. Given the lack of research on the use of SBIRT
with offenders, it is premature to conduct a full cost-
effectiveness or benefit-cost analysis. However, the cost
analysis will provide policy-relevant information with
regard to the cost of providing SBIRT to a jail popula-
tion. Should the intervention prove to be effective in
this study, the cost data will lay the foundation for a
proposal to conduct a comprehensive benefit-cost ana-
lysis of SBIRT with offenders.
Interview training and procedures
Prior to training, interviewers will need to receive clear-
ance to work in the jails. The ISAP Training Unit and
project research staff will provide a five-day training that
consists of the regular ISAP training modules required
of all interviewers: Good Research Practices, Safety Con-
cerns in Dealing with Patients, and Data Collection Pro-
cedures. The training will also cover 1) familiarization
with study aims, instruments, and interview procedures
specific to the study; 2) confidentiality and informed
consent, data integrity, and data security; 3) issues and
cautions in working with offenders; 4) observation of
mock interviews conducted by the project director; and
5) practice interviews with the project director. Inter-
viewers will also receive “red flag” training on how to
recognize and respond to danger to self and others, child
abuse, elder/dependent adult abuse, and domestic vio-
lence. Interviewers will receive annual refresher training
on these topics.
The baseline interviews will be conducted in a private
office at the jail. The follow-up interviews will occur at
locations that are safe, ensure privacy, and minimize travel
costs. Follow-up interviews may be conducted in jails or
prisons. If a face-to-face interview is not possible (e.g., the
participant is located out of state), the interview will be
conducted by telephone. When setting up the follow-up
interview, and again at the interview, the interviewer will
confirm the identity of the participant by asking for full
name and birth date. As a quality check, the project dir-
ector will call a 10% random sample of participants for
whom follow-up interview forms are on file to verify that
the interview took place. Weekly project meetings with re-
search staff will enable problems in recruitment and data
collection to be quickly identified and addressed. Several
procedures will help standardize data collection and en-
courage accuracy and honesty in reporting, as follows: 1)
trained interviewers will conduct the interviews; 2) a pri-
vate interview setting will minimize distractions and ensureconfidentiality; 3) interviewers will remind participants of
the confidentially of the information that they provide; 4)
interviewers will be attentive to signs of fatigue and offer
breaks if necessary; and 5) interviewers will be trained to
look for reporting inconsistencies and socially desirable
versus honest responses.
Participants will be paid $20 for the baseline interview,
$50 for the follow-up interview, and $10 for two volun-
tary oral fluids samples (one for drugs, the other for al-
cohol) at follow-up. For interviews in the community,
payment will be in the form of a gift card provided imme-
diately following the interview (or mailed if a telephone
interview). For interviews conducted in jail or prison, pay-
ment will be in the form of either money order or cash
(depending on institution procedures) deposited to the in-
mate’s trust account.
Tracking and locating for 12-month follow-up interviews
At baseline, the interviewer will ask participants to fill
out a Locator Form. This form contains information that
is useful for locating participants for follow-up inter-
views (e.g., driver’s license; names, addresses, and phone
numbers of immediate relatives and unrelated friends;
areas of town frequented; locations where social services
are received; and probation or parole officer contacts).
Other tracking resources include local and state correc-
tional agencies that maintain publicly available websites
that can be searched to determine whether a subject is
in jail or prison or is on probation or parole. We will
use a program developed in FileMakerPro® for previous
ISAP studies to record information needed for the tracking
and locating process (e.g., locator data, agency contacts, let-
ters, telephone calls, appointments). Tracking and locating
procedures are described in a manual that was developed at
ISAP [42] and is widely distributed by NIDA and CSAT.
These procedures have been used by ISAP researchers in
many studies to track and locate subjects for as long as
10 years between interview points, with follow-up rates typ-
ically at 85% or more [43]. Follow-up interviews have been
conducted with subjects who are homeless, who are in jail
or prison, who have absconded from probation or parole
supervision, or who reside in other states or countries. In
short, we expect that the detailed locator information from
participants and the successful strategies used in previous
studies will enable us to locate 90% of the baseline sample
and, allowing for refusals and deaths, to interview at least
85% of the sample at the 12-month follow-up. We will ob-
tain criminal justice and treatment records covering the 12-
month follow-up period on all participants.
Analysis plan
Variables
The independent variable for analysis is treatment sta-
tus (i.e., assignment to either the SBIRT group or the
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in accordance with Consolidated Standards of Reporting
Trials (CONSORT) recommendations for randomized tri-
als [44], we divided the dependent variables (outcomes)
into primary and secondary. The power analysis is based
on detecting effects for the primary outcomes. The two
primary outcomes are reductions in the use of drugs and
of alcohol (based on self-report and biological testing).
The secondary outcomes are participation in treatment
(based on self-report and records) and in self-help groups
(based on self-report); rearrest and incarceration (based
on records); quality of life (based on self-report); and HIV
risk behaviors (based on self-report).
Hypotheses
The analyses will test the two primary hypotheses and
four secondary hypotheses. The primary hypotheses
are that, over the 12-month follow-up period, clients
in the SBIRT group will be 1) more likely to reduce
their level of drug use and 2) more likely to reduce
their level of alcohol use compared with clients in the
control group. The secondary hypotheses are that,
over the 12-month follow-up period, clients in the SBIRT
group will be 1) more likely to participate in brief treat-
ment and/or longer-term treatment and to participate
in AA, NA, or other self-help groups; 2) less likely to
be arrested and incarcerated; 3) more likely to have a
higher quality of life; and 4) less likely to engage in HIV
risk behaviors compared with clients in the comparison
group.
Research questions
The study will also examine several research questions
related to participation, implementation, and cost:
Participation
1. How many inmates agreed to be in the study? What
reasons were given for any refusals?
2. Of those assigned to the SBIRT group, what
percentage was screened?
3. Of those screened, what percentage scored at each
risk level?
4. Of those who scored at moderate or high risk, what
percentage participated in brief treatment and/or
longer-term treatment?
5. What was the level of satisfaction with the type of
intervention received?
Implementation
6. What problems were encountered in setting up and
implementing SBIRT in a jail setting?
7. What problems were encountered in recruiting
participants and in delivering the intervention?Cost
8. How much does it cost to provide the SBIRT
intervention to men and women inmates?
Preliminary analysis
Equivalency between study groups will be examined on
baseline characteristics that are correlated with out-
comes. Attrition bias will be examined using baseline
characteristics to compare those who complete follow-
up with those who do not. Oral-fluid test results will be
used to assess the validity of self-report of drugs and al-
cohol. Records data will be compared with self-report on
treatment participation and criminal justice involvement.
Missing data
The main strategy to reduce missing data will be to train
and monitor interviewers to ensure that all questions are
answered. In analyses, missing data will be explored
through frequency distributions. Missing data will be ad-
dressed using maximum likelihood (ML) or multiple im-
putation (MI) estimates for incomplete data [45,46].
Alternatively, statistical techniques that allow for missing
data may be used (e.g., generalized linear models).
Hypothesis testing
Data from the baseline and the 12-month follow-up in-
terviews and from records will be used to test the hy-
potheses. Analyses will be based on the intent-to-treat
principle. Primary outcome 1 for drug use and primary
outcome 2 for alcohol use, measured as dichotomous
outcomes at follow-up, will be tested using chi-square
analysis. Measured as change over time, the two hypoth-
eses will be tested using repeated measures Generalized
Estimating Equations (GEE) modeling, available in SAS
proc GENMOD [47]. If the two groups differ signifi-
cantly at baseline on drug or alcohol use variables or on
other variables, logistic regression analysis will be used
to assess the group effect for the drug and alcohol use
outcomes, controlling for the covariates. Secondary out-
come 1 for participation in treatment and self-help groups
will be measured as a dichotomous variable and will be
analyzed using either chi-square or logistic regression ana-
lysis. For secondary outcome 2 on arrest and incarceration,
Cox proportional hazards regression [48] will be used to
analyze the group difference in terms of elapsed time to
re-arrest and re-incarceration. For secondary outcome 3,
quality of life, the score on the WHO Quality of Life meas-
ure is continuous and will be analyzed using t-tests or, if
baseline covariates need to be controlled, a multiple re-
gression model. The outcome for secondary outcome 4,
HIV risk behavior, will be measured as involvement in
total number of risky behaviors and will be analyzed using
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ables, by using a multiple regression model.
For the primary outcomes, an effect size will be calcu-
lated. The index of effect size will be the standardized mean
difference (calculated as the difference between the means
on the outcome variable for the two groups divided by the
pooled standard deviation); for proportions, the equivalent
effect size is calculated using the arc sine transformation
[49]. Effect sizes will provide a quantitative measure of the
magnitude of the difference between groups; they will also
be useful in calculating power for future studies of SBIRT.
Cost analysis
Cost analysis will focus on estimating and comparing
total intervention costs for the SBIRT and the compari-
son groups. This will allow us to report both the total
and incremental cost of SBIRT. The incremental cost is
the additional cost (above the cost of services offered to
comparison clients) of SBIRT. Specifically, we will calcu-
late total annual cost, average weekly cost per client, and
average cost per treatment episode for both groups. To
highlight the relative contribution of the cost compo-
nents, we will calculate the percentage of total annual
cost accounted for by each cost category. The data ana-
lysis routines for the DATCAP have been used in prior
studies [50,51].
Other analyses
Additional analyses, while not testing specific hypoth-
eses, will address related topics of interest, such as dif-
ferences in outcomes by risk level, stage of change, and
readiness for treatment. Since such analyses may involve
subgroups with insufficient cell size to meet power re-
quirements, findings will be considered tentative.
Discussion
The purpose, setting, and design of the study of SBIRT
with jail inmates make it a pragmatic trial, as defined by
Zwarenstein et al. [52], namely, a study with design
choices that “maximise applicability of the trial’s results
to usual care settings, rely on unarguably important out-
comes such as mortality and severe morbidity, and are
tested in a wide range of participants.” The study is ex-
pected to advance knowledge of SBIRT in several ways.
First, virtually all of the evaluation and dissemination
work on SBIRT has occurred in health-care settings, with
little or no attention to the potential benefit of SBIRT for
the large population of offenders, most of whom are at
risk for drug and/or alcohol problems and for rearrest or
supervision violation. Although a few studies have evalu-
ated brief interventions with offenders, this study will
examine the effectiveness of the full spectrum of SBIRT
components. To our knowledge, this would be the first
experimental study of the effectiveness of SBIRT withoffenders. Second, whereas most previous research on
SBIRT has focused on alcohol, the study will expand the
relatively limited evidence base on the effectiveness of
SBIRT with persons who use drugs (or drugs and alcohol).
Third, the study supplements the brief intervention and
the treatment referral components of SBIRT with a BT
protocol for offenders who are at moderate risk or for
those who are not willing to commit to longer-term treat-
ment. Fourth, unlike most studies of SBIRT, this study will
examine the effects of SBIRT on HIV risk behaviors. Fi-
nally, the study will collect needed information on the
costs associated with providing SBIRT to an offender pop-
ulation. The study may face a number of challenges that
may limit the validity or generalizability of the findings, al-
though we will take steps to limit their effect.
Recruitment
Given the large number of inmates being released from
the jail each day, recruitment goals should be able to be
met even with a relatively high refusal rate. But if numbers
do fall short, we will identify reasons that inmates refuse
participation and attempt to correct them, confer with jail
staff to address any logistical issues, extend the recruit-
ment period, or recruit at other county jail facilities.
Randomization violations
The project director will closely monitor the randomization
protocol to ensure the integrity of assignment (i.e., there
are no crossovers from one group to another). Should
problems occur, solutions will be discussed with research
and counseling staff. Even if crossovers do occur, analyses
of hypotheses will use the intent-to-treat principle.
Attrition and self-report data
Every effort will be made to retain all participants in the
study and to interview all participants at follow-up. Track-
ing and locating procedures described above should min-
imize attrition. Virtually complete data will be available for
outcomes based on administrative records. Although there
is often concern about the validity of self-report, prior re-
search indicates that self-report interviews, when properly
conducted, are generally reliable and valid in measuring
drug and alcohol use [53,54] and criminal involvement
[55]. The strategies discussed above will increase reliability
and validity of self-report data.
Research effects
A number of researchers [10,56-58] have noted that the
intervention effects of brief interventions may be con-
founded with research effects—that is, research assess-
ments may have a therapeutic effect for all subjects, thus
diluting treatment effects. Although this study will not
formally assess this possibility through manipulation, we
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limiting the amount of data collected at baseline.Generalizability
The study participants will probably not be typical of in-
mates who would be the intended population of SBIRT
in routine practice. They are willing to participate in re-
search activities, are compensated for their participation
in research, and receive an intervention from carefully
trained and monitored counselors. These necessary re-
search conditions would not be present in a typical setting
that provided SBIRT to offenders, and thus, the effects
found may be attenuated in a “real world” setting.Conclusion
Screening, brief intervention, and referral to treatment
provides a bridge between primary prevention and treat-
ment by conducting early identification and intervention
with people whose current use may be low but who are
at risk for future alcohol and drug problems and by re-
ferring those with likely abuse or dependence to longer-
term treatment. The public health assumption informing
SBIRT is that individual reductions in alcohol and drug
use, when aggregated over a large at-risk population, can
have significant health, public health, and public safety
effects [59]. As noted above, while SBIRT has been found
to be effective in some health-care settings (and to a lesser
extent in colleges and universities), little published research
is available on the use of SBIRT to identify offenders at dif-
ferent risk levels and to provide appropriate levels of inter-
vention. Should SBIRT prove effective with this population,
it would offer a proactive approach to help offenders reduce
drug and alcohol use, HIV risk behaviors, and criminal be-
havior and improve their psychosocial functioning. As such,
the wider dissemination of SBIRT to criminal justice set-
tings statewide or nationwide could have a significant im-
pact on public health and public safety.
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